NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

遺傳性檢驗市場 - 市場佔有率,市場規模,趨勢,產業分析:2020年∼2027年

Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology (Cytogenetic, Biochemical, Molecular Testing); By Regions; Segment Forecast, 2020 - 2027

出版商 Polaris Market Research 商品編碼 986415
出版日期 內容資訊 英文 121 Pages
商品交期: 最快1-2個工作天內
價格
遺傳性檢驗市場 - 市場佔有率,市場規模,趨勢,產業分析:2020年∼2027年 Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology (Cytogenetic, Biochemical, Molecular Testing); By Regions; Segment Forecast, 2020 - 2027
出版日期: 2020年12月01日內容資訊: 英文 121 Pages
簡介

全球遺傳性檢驗的市場規模,至2027年達到92億9,000萬美元。遺傳性疾病的適時診斷和主要企業對成本效益高的治療選擇的需求高漲,是促進市場成長的重要要素。

本報告提供全球遺傳性檢驗市場相關調查分析,有關目前市場動態的詳細的考察,未來的市場成長的分析相關的系統性資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 遺傳性檢驗市場考察

  • 遺傳性檢驗:產業的概述
  • 遺傳性檢驗市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • 大環境分析
  • 遺傳性檢驗市場產業趨勢

第5章 遺傳性檢驗市場評估:各疾病類型

  • 主要調查結果
  • 簡介
  • 癌症
  • 癌症以外

第6章 全球遺傳性檢驗市場:各技術

  • 主要調查結果
  • 簡介
  • 細胞遺傳學
  • 生物化學
  • 分子檢驗

第7章 遺傳性檢驗市場評估:各地區

  • 主要調查結果
  • 簡介
  • 遺傳性檢驗市場:北美
  • 遺傳性檢驗市場:歐洲
  • 遺傳性檢驗市場:亞太地區
  • 遺傳性檢驗市場:中東、非洲
  • 遺傳性檢驗市場:南美

第8章 競爭情形

  • 擴張與收購分析
  • 夥伴關係/合作/契約/展示會

第9章 企業簡介

  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Illumina, Inc.
  • Natera, Inc.
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Twist Bioscience Inc.
  • Sophia Genetics
  • Fulgent Genetics
目錄
Product Code: PM1774

The global hereditary testing market expected to reach USD 9.29 billion by 2027 according to a new study by Polaris Market Research. The report "Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology (Cytogenetic, Biochemical, Molecular Testing); By Regions; Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing need for timely diagnosis of genetic hereditary diseases and launch of cost-effective treatment options by the key players are the key factors responsible for market growth. According to the market statistics published by the organization dedicated for the rare diseases, over 300 million people are currently suffering from around 6,000 identified forms of rare disorders worldwide.

Technological advancements in the marketspace and use of cloud-based distribution model for laboratories to avail the bioinformatics is expected to have a positive impact on the hereditary testing growth. Furthermore, the increasing test volumes for genetic tests across the developed economies is expected to drive market demand for hereditary testing over the forecast period.

Segment Highlights

The hereditary cancer testing market segment accounted for the largest revenue segment in 2019 owing to the increasing genetic tests for cancer in developed economies such as the U.S., UK, Canada, and France, among others

Europe market accounted for the largest revenue share in 2019 owing to the increasing tests across the region and technological advancement in the field of testing is expected to drive the market growth of hereditary tests over the forecast period

List of Key Players:

Myriad Genetics, Inc.

Invitae Corporation

Illumina, Inc.

Natera, Inc.

Hoffmann-La Roche Ltd

Quest Diagnostics

Agilent Technologies, Inc.

Twist Bioscience

Sophia Genetics

Fulgent Genetic, Inc.

Medgenome

CENTOGENE N.V.

Others

Polaris Market Research has segmented the hereditary testing market report on the basis of disease type, technology, and region

Hereditary Testing, Disease Type Outlook (Revenue - USD Million, 2016 - 2027)

Hereditary Cancer Testing

Lung Cancer

Breast Cancer

Colorectal Cancer

Cervical Cancer

Ovarian Cancer

Prostate Cancer

Stomach/Gastric Cancer

Melanoma

Sarcoma

Uterine Cancer

Pancreatic Cancer

Others

Hereditary Non-Cancer Testing

Genetic Tests

Cardiac Diseases

Rare Diseases

Other Diseases

Newborn Genetic Screening

Preimplantation Genetic Diagnosis & Screening

Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

Hereditary Testing, Technology Outlook (Revenue - USD Million, 2016 - 2027)

Cytogenetic Testing

Biochemical Testing

Molecular Testing

Hereditary Testing Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Hereditary Testing Market Insights

  • 4.1. Hereditary Testing - Industry snapshot
  • 4.2. Hereditary Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rapid innovations in the hereditary testing
      • 4.2.1.2. Growing prevalence of hereditary diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Efficacy of the testing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Hereditary Testing Market Industry trends

5. Hereditary Testing Market Assessment by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • 5.3. Hereditary Cancer Testing
    • 5.3.1. Global Hereditary Testing Market, by Hereditary Cancer Testing, by Region, 2016 - 2027 (USD Million)
    • 5.3.2. Lung Cancer
      • 5.3.2.1. Hereditary Cancer Testing, for Lung Cancer, 2016 - 2027 (USD Million)
    • 5.3.3. Breast Cancer
      • 5.3.3.1. Hereditary Cancer Testing, for Breast Cancer, 2016 - 2027 (USD Million)
    • 5.3.4. Colorectal Cancer
      • 5.3.4.1. Hereditary Cancer Testing, for Colorectal Cancer, 2016 - 2027 (USD Million)
    • 5.3.5. Cervical Cancer
      • 5.3.5.1. Hereditary Cancer Testing, for Cervical Cancer, 2016 - 2027 (USD Million)
    • 5.3.6. Ovarian Cancer
      • 5.3.6.1. Hereditary Cancer Testing, for Ovarian Cancer, 2016 - 2027 (USD Million)
    • 5.3.7. Prostate Cancer
      • 5.3.7.1. Hereditary Cancer Testing, for Prostate Cancer, 2016 - 2027 (USD Million)
    • 5.3.8. Stomach/Gastric Cancer
      • 5.3.8.1. Hereditary Cancer Testing, for Stomach/Gastric Cancer, 2016 - 2027 (USD Million)
    • 5.3.9. Melanoma
      • 5.3.9.1. Hereditary Cancer Testing, for Melanoma, 2016 - 2027 (USD Million)
    • 5.3.10. Sarcoma
      • 5.3.10.1. Hereditary Cancer Testing, for Sarcoma, 2016 - 2027 (USD Million)
    • 5.3.11. Uterine Cancer
      • 5.3.11.1. Hereditary Cancer Testing, for Uterine Cancer, 2016 - 2027 (USD Million)
    • 5.3.12. Pancreatic Cancer
      • 5.3.12.1. Hereditary Cancer Testing, for Pancreatic Cancer, 2016 - 2027 (USD Million)
    • 5.3.13. Others
      • 5.3.13.1. Hereditary Cancer Testing, for Other Cancer, 2016 - 2027 (USD Million)
  • 5.4. Hereditary Non-Cancer Testing
    • 5.4.1. Global Hereditary Testing Market, by Hereditary Non-Cancer Testing, by Region, 2016 - 2027 (USD Million)
    • 5.4.2. Non-cancer Genetic Tests
      • 5.4.2.1. Hereditary non-cancer genetic testing market, 2016 - 2027 (USD Million)
      • 5.4.2.2. Cardiac Diseases
      • 5.4.2.2.1. Hereditary non-cancer genetic testing market for Cardiac Diseases, 2016 - 2027 (USD Million)
      • 5.4.2.3. Rare Diseases
      • 5.4.2.3.1. Hereditary non-cancer genetic testing market for Rare Diseases, 2016 - 2027 (USD Million)
      • 5.4.2.4. Other Diseases
      • 5.4.2.4.1. Hereditary non-cancer genetic testing market for Other Diseases, 2016 - 2027 (USD Million)
    • 5.4.3. Newborn Genetic Screening
      • 5.4.3.1. Hereditary Newborn Genetic Screening market, 2016 - 2027 (USD Million)
    • 5.4.4. Preimplantation Genetic Diagnosis & Screening
      • 5.4.4.1. Hereditary Preimplantation Genetic Diagnosis & Screening market, 2016 - 2027 (USD Million)
    • 5.4.5. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
      • 5.4.5.1. Hereditary Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests market, 2016 - 2027 (USD Million)

6. Global Hereditary Testing Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 6.3. Cytogenetic
    • 6.3.1. Global Hereditary Testing Market, by Cytogenetic, By Region, 2016 - 2027 (USD Million)
  • 6.4. Biochemical
    • 6.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2016 - 2027 (USD Million)
  • 6.5. Molecular Testing
    • 6.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2016 - 2027 (USD Million)

7. Hereditary Testing Market Assessment by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • 7.3. Hereditary Testing Market - North America
    • 7.3.1. North America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
    • 7.3.2. North America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.3.3. Hereditary Testing Market - U.S.
      • 7.3.3.1. U.S.: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.3.3.2. U.S.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.3.4. Hereditary Testing Market - Canada
      • 7.3.4.1. Canada: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.3.4.2. Canada.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 7.4. Hereditary Testing Market - Europe
    • 7.4.1. Europe: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
    • 7.4.2. Europe: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.3. Hereditary Testing Market - UK
      • 7.4.3.1. UK: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.3.2. UK: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.4. Hereditary Testing Market - France
      • 7.4.4.1. France: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.4.2. France: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.5. Hereditary Testing Market - Germany
      • 7.4.5.1. Germany: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.5.2. Germany: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.6. Hereditary Testing Market - Italy
      • 7.4.6.1. Italy: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.6.2. Italy: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.7. Hereditary Testing Market - Spain
      • 7.4.7.1. Spain: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.7.2. Spain: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.8. Hereditary Testing Market - Netherlands
      • 7.4.8.1. Netherlands: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.8.2. Netherlands: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.4.9. Hereditary Testing Market - Austria
      • 7.4.9.1. Austria: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.4.9.2. Austria: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 7.5. Hereditary Testing Market - Asia-Pacific
    • 7.5.1. Asia Pacific: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
    • 7.5.2. Asia Pacific: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.3. Hereditary Testing Market - China
      • 7.5.3.1. China: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.3.2. China: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.4. Hereditary Testing Market - India
      • 7.5.4.1. India: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.4.2. India.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.5. Hereditary Testing Market - Malaysia
      • 7.5.5.1. Malaysia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.5.2. Malaysia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.6. Hereditary Testing Market - Japan
      • 7.5.6.1. Japan: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.6.2. Japan: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.7. Hereditary Testing Market - Indonesia
      • 7.5.7.1. Indonesia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.7.2. Indonesia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.5.8. Hereditary Testing Market - South Korea
      • 7.5.8.1. South Korea: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.5.8.2. South Korea.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 7.6. Hereditary Testing Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
    • 7.6.2. Middle East & Africa.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.6.3. Hereditary Testing Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.6.3.2. Saudi Arabia.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.6.4. Hereditary Testing Market - UAE
      • 7.6.4.1. UAE: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.6.4.2. UAE: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.6.5. Hereditary Testing Market - Israel
      • 7.6.5.1. Israel: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.6.5.2. Israel: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.6.6. Hereditary Testing Market - South Africa
      • 7.6.6.1. South Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.6.6.2. South Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • 7.7. Hereditary Testing Market - Latin America
    • 7.7.1. Latin America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
    • 7.7.2. Latin America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.7.3. Hereditary Testing Market - Mexico
      • 7.7.3.1. Mexico: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.7.3.2. Mexico.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.7.4. Hereditary Testing Market - Brazil
      • 7.7.4.1. Brazil: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.7.4.2. Brazil.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
    • 7.7.5. Hereditary Testing Market - Argentina
      • 7.7.5.1. Argentina: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
      • 7.7.5.2. Argentina.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Myriad Genetics, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product/Services Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Invitae Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product/Services Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Illumina, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product/Services Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Natera, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product/Services Benchmarking
    • 9.4.4. Recent Development
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product/Services Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Quest Diagnostics Incorporated
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product/Services Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Agilent Technologies, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product/Services Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Twist Bioscience Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product/Services Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Sophia Genetics
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product/Services Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Fulgent Genetics
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product/Services Benchmarking
    • 9.10.4. Recent Development

Truncated List of Tables

  • Table 1 Global Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 2 Global Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 3 Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 4 North America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 5 North America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 6 U.S.: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 7 U.S.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 8 Canada: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 9 Canada: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 10 Europe: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 11 Europe: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 12 UK: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 13 UK: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 14 France: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 15 France: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 16 Germany: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 17 Germany: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 18 Italy: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 19 Italy: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 20 Spain: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 21 Spain: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 22 Netherlands: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 23 Netherlands: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 24 Austria: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 25 Austria: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 26 Asia Pacific: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 27 Asia Pacific: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 28 China: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 29 China: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 30 India: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 31 India: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 32 Malaysia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 33 Malaysia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 34 Japan: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 35 Japan: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 36 Indonesia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 37 Indonesia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 38 South Korea: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 39 South Korea: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 40 Middle East & Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 41 Middle East & Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 42 Saudi Arabia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 43 Saudi Arabia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 44 UAE: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 45 UAE: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 46 Israel: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 47 Israel: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 48 South Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 49 South Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 50 Latin America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 51 Latin America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 52 Mexico: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 53 Mexico: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 54 Brazil: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 55 Brazil: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
  • Table 56 Argentina: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 57 Argentina: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)

List of Figures

Figure 1 Market Highlights (2019, Revenue)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top Down & Bottom Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Disease Type

Figure 7 Global Hereditary Testing Market, By Disease Type, 2019 & 2027 (USD Million)

Figure 8 Market by Technology

Figure 9 Global Hereditary Testing Market, By Technology, 2019 & 2027 (USD Million)

Figure 10 Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)

Figure 11 Strategic Analysis - Hereditary Testing Market